GlassScriptPhysician profile
Ryan A Preston
NPI 1801360623
$965.83
in general payments reported to CMS, 2019-2025
9 companies · $664 in 2025
The $664 reported for 2025 was more than what 98% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
See the full distribution for Nurse Anesthetist, Certified Registered
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $28.83 · 2022: $30.27 · 2023: $113 · 2024: $130 · 2025: $664.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $907.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $906.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aop Health US, LLC | $519.03 | 2025 | Rapiblyk |
| Merck Sharp & Dohme LLC | $169.50 | 2021-2025 | Bridion |
| Fisher & Paykel Healthcare INC | $75.53 | 2024-2025 | Fisher & Paykel Healthcare |
| Eagle Pharmaceuticals, INC. | $62.68 | 2023-2024 | |
| Vertex Pharmaceuticals Incorporated | $40.29 | 2024-2025 | |
| La Jolla Pharmaceutical Company | $37.75 | 2022-2023 | Giapreza |
| Octapharma USA, INC. | $27.40 | 2025 | Fibryga |
| Chiesi USA, INC. | $19.98 | 2025 | Cleviprex |
| Trevena, INC. | $13.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Preston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.